NRx Pharmaceuticals, Inc. (NRXP)
Pre-market:
- Simply Wall St.
How Much Of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Do Insiders Own?
Every investor in NRx Pharmaceuticals, Inc. ( NASDAQ:NRXP ) should be aware of the most powerful shareholder groups...
- GlobeNewswire
NRx Reports Remarks by Israel Institute for Biological Research on the future of the BriLife™ Covid-19 Investigational Vaccine
Remarks by Dr. Shmuel Yitzhaki, as published in Globes, an Israeli business newspaperBriLife vaccine may have better neurtralizing ability against Omicron variant than first generation mRNA vaccines, according to IIBR findings RADNOR, Pa., Feb. 11, 2022 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals (Nasdaq: NRXP), a clinical-stage, biopharmaceutical company, today reported remarks by Dr. Shmuel Yitzhaki, Director of the Israel Institute for Biological Research, who spoke at the Eli Hurvitz Institute f
- GlobeNewswire
NRx Pharmaceuticals Announces Expansion of ZYESAMI® (aviptadil) US Expanded Access and Right to Try Programs for Patients with COVID-19 Respiratory Failure who have Exhausted All Approved Treatments
ZYESAMI® (aviptadil) is currently in a Phase 3 clinical trial being conducted by the National Institutes of Health (NIH)NRx will continue to provide ZYESAMI to hospitals enrolled in NRx’s Expanded Access Protocol under US Food and Drug Administration guidelinesNRx is also making ZYESAMI available as an investigational medicine under the Federal Right to Try Act1ZYESAMI is available to patients who have progressed despite treatment with remdesivir and other approved medicines and who are not able
